Sertraline and Panobinostat: Interaction Details
AI-assisted, pharmacist-reviewed · AI content regenerated Jul 11, 2026 · Source data updated Jul 2, 2026 · Sources: FDA labeling, DDInter 2.0, cited literature
Sertraline
No brand names on recordPanobinostat
How we grade severity & evidence
Severity levels
- Contraindicated: These should generally not be used together.
- Major: Potentially serious — often needs a change or close monitoring.
- Moderate: Can be significant — usually manageable with monitoring.
- Minor: Usually limited clinical impact.
Evidence grades
- Established: Well documented — supported by controlled studies or strong clinical data.
- Probable: Good supporting evidence, though not definitively proven.
- Suspected: Some evidence suggests this interaction, but it is not well established.
- Possible: Limited or conflicting evidence; the interaction may occur.
- Theoretical: Predicted from the drugs' pharmacology; not yet confirmed in people.
Ratings come from the documented interaction literature and are reviewed by a pharmacist. They describe the documented risk of the combination, not what will necessarily happen to you — your dose, timing, and health picture all matter.
You've been prescribed sertraline (an antidepressant) and panobinostat (a cancer medicine). Both of these drugs can affect the timing of your heartbeat in a way doctors call QT prolongation. When two medicines that each do this are taken together, the effect can add up and, in rare cases, lead to an irregular heartbeat.
This concern is based on how the drugs work rather than lots of real-world reports, but because the heart is involved, your care team takes it seriously. Please don't stop either medicine on your own. Talk with your doctor or pharmacist, who can decide the safest plan for you and keep a close eye on your heart if needed.
Effect: Additive QT interval prolongation with increased risk of ventricular arrhythmias (including torsades de pointes) when sertraline is combined with panobinostat.
Mechanism: Pharmacodynamic additivity; both agents independently prolong the QT interval. Neither is a prodrug here, so effect direction is straightforward summation.
- Severity: Major
- Onset: Unspecified
- Evidence: Theoretical
- Management: Avoidance is recommended. If coadministration is unavoidable, obtain baseline and periodic ECGs, correct electrolytes (K+, Mg2+), and monitor for arrhythmia symptoms. Consider alternative agents.
What happens
An increased risk of QT interval prolongation
Interaction Deep Dive
Because the combination can raise the likelihood of QT prolongation and/or ventricular arrhythmias, sertraline and this drug should not be given together1.
Why it happens (mechanism)
Additive QT interval prolongation
How to manage this interaction
Both medicines can lengthen the QT interval, so the guidance on file is to avoid using them together when possible. Your care team may take steps such as:
- Choosing an alternative to one of the drugs.
- Checking your heart rhythm with an ECG before and during treatment.
- Monitoring and correcting electrolytes like potassium and magnesium.
Keep taking both exactly as prescribed until you speak with your prescriber or pharmacist. Ask them whether an alternative makes sense for you, and report symptoms like fainting, palpitations, or dizziness right away.
Management is individual — confirm any change with your pharmacist or prescriber.
Common questions
Can I take Sertraline and Panobinostat together?
Sertraline and panobinostat can each prolong the QT interval, and using them together raises the risk of a dangerous heart rhythm, so the recommendation is to avoid the combination. Check with your doctor or pharmacist about alternatives or closer heart monitoring. Always confirm with your pharmacist or prescriber before making any change.
How serious is the Sertraline and Panobinostat interaction?
It is rated major. Potentially serious — often needs a change or close monitoring.
How quickly could this interaction happen?
The documented onset is "unspecified". The timing of this interaction is not well characterized.
How is the Sertraline and Panobinostat interaction managed?
Both medicines can lengthen the QT interval, so the guidance on file is to avoid using them together when possible. Your care team may take steps such as: Choosing an alternative to one of the drugs. Checking your heart rhythm with an ECG before and during treatment. Monitoring and correcting electrolytes like potassium and magnesium. Keep taking both exactly as prescribed until you speak with you… Management is individual — always follow your own care team's guidance.
How strong is the evidence for this interaction?
The evidence is graded "theoretical". Predicted from the drugs' pharmacology; not yet confirmed in people.
From our Q&A
Real reader questions about these medications, each personally answered by our pharmacist:
Questions for your pharmacist
- Does my dose of Sertraline or Panobinostat need adjusting while I take them together?
- What symptoms should prompt me to call you or my prescriber right away?
- Does the timing of my doses matter for this combination?
- Is there a safer alternative to one of these medications for me?
References (1)
- Product Information: ZOLOFT oral tablets, oral solution, sertraline hydrochloride oral tablets, oral solution. Viatris Specialty LLC (per FDA), Morgantown, WV, 2023. DailyMed
Keep reading about Sertraline
Keep reading about Panobinostat
These medications also interact with supplements
Prescription drugs aren't the whole picture — herbal and dietary supplements can interact with them too. From the evidence-graded Natural Medicines database:
major · moderate · minor — check everything you take with our drug–supplement interaction checker.
Check another combination
Our instant two-drug interaction checker is almost here.
Still have questions about this combination?
Every question gets a real answer from a licensed pharmacist — free, and usually within a day.
Ask the pharmacist